Title: Safety of Everolimus Plus Exemestane In Patients With Hormone-Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Progressing on Prior Non-Steroidal Aromatase Inhibitors: Primary Results of a Phase 3b, Open-Label, Single-Arm, Expanded-Access Multicenter Trial (BALLET)
Authors: Jerusalem, G ×
Mariani, G
Ciruelos, E M
Martin, M
Tjan-Heijnen, V C G
Neven, Patrick
Gavila, J G
Michelotti, A
Montemurro, F
Generali, D
Simoncini, E
Lang, I
Mardiak, J
Naume, B
Camozzi, M
Lorizzo, K
Bianchetti, S
Conte, P #
Issue Date: Sep-2016
Publisher: Kluwer Academic Publishers
Series Title: Annals of Oncology vol:27 issue:9
Article number: mdw249
Abstract: This European phase 3b, expanded-access multicenter trial evaluated the safety of EVE plus EXE in a patient population similar to BOLERO-2.
ISSN: 0923-7534
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Gynaecological Oncology
× corresponding author
# (joint) last author

Files in This Item:
File Description Status SizeFormat
Annals Oncol 2016.pdf Accepted 516KbAdobe PDFView/Open


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science